Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia
(IBMPFD) is a dominant progressive disorder that maps to chromosome 9p21.1–p12. We …

Algorithms designed to identify canonical yeast prions predict that around 250 human
proteins, including several RNA-binding proteins associated with neurodegenerative disease, …

Recently, the excitatory amino acid neurotransmitter glutamate was implicated in the
pathogenesis of a variety of chronic degenerative neurological diseases in humans and animals. …

MATR3 is an RNA- and DNA-binding protein that interacts with TDP-43, a disease protein
linked to amyotrophic lateral sclerosis (ALS) and frontotemporal dementia. Using exome …

To identify novel causes of familial neurodegenerative diseases, we extended our previous
studies of TAR DNA‐binding protein 43 (TDP‐43) proteinopathies to investigate TDP‐43 as …

Background Pompe's disease is a metabolic myopathy caused by a deficiency of acid alpha
glucosidase (GAA), an enzyme that degrades lysosomal glycogen. Late-onset Pompe's …

Objective Myostatin is an endogenous negative regulator of muscle growth and a novel target
for muscle diseases. We conducted a safety trial of a neutralizing antibody to myostatin, …

Background Mutations in SOD1 cause 13% of familial amyotrophic lateral sclerosis. In the
SOD1 Gly93Ala rat model of amyotrophic lateral sclerosis, the antisense oligonucleotide ISIS …

Mutations in the mitochondrial fusion protein mitofusin 2 (MFN2) are the most commonly
identified cause of Charcot-Marie-Tooth type 2 (CMT2), a dominantly inherited disease …

Daily injections into mice of an ammonium sulfate-precipitated immunoglobulin fraction of
serum from patients with myasthenia gravis were carried out for up to 14 days. The mice …